factory supply WAY 316606//Setipiprant//Fevipiprant//RU58841//CB-03-01//OC000459 anti-hair loss solution

FOB Reference Price:Get Latest Price
$50.00 - $120.00 / Grams | 1 Gram/Grams (Min. Order)
Lead Time:
Quantity(Grams) 1 - 100 >100
Est. Time(days) 7 Negotiable
Report Suspicious Activity
Overview
Quick Details
CAS No.:
915759-45-4
Other Names:
WAY316606
MF:
C18H19F3N2O4S2
EINECS No.:
N/M
Place of Origin:
Hubei, China (Mainland)
Type:
Antibiotic and Antimicrobial Agents, Antiparasitic Agents
Grade Standard:
Medicine Grade
Brand Name:
HHD-PHARM
Model Number:
HHD
Purity:
99%
COLOR:
WHITE
WAY 316606:
915759-45-4
RU 58841:
154992-24-2
setipiprant:
866460-33-5
Fevipiprant:
872365-14-5
OC000459:
851723-84-7
Supply Ability
Supply Ability:
100 Gram/Grams per Month
Packaging & Delivery
Packaging Details
ON REQUEST
Port
SH
Lead Time :
Quantity(Grams) 1 - 100 >100
Est. Time(days) 7 To be negotiated

 Anti-hair loss products

           

 

         WAY 316606 

 

     CAS:915759-45-4

      

 

     

 

CB-03-01

 

CAS:19608-29-8

 

     

 

 

 

 

 

RU 58841

 

CAS:154992-24-2

 

    

 

 

 

OC000459

 

CAS: 851723-84-7

      

 

fevipiprant

 

CAS: 872365-14-5

 

 

    

 

 

Seipiprant

 

CAS: 866460-33-5

 

 

 WAY 316606 

Description: Secreted Frizzled-related protein-1 (sFRP-1) inhibitor; increases Wnt signaling

 

CB-03-01

Cortexolone 17 alpha-propionate (CB-03-01) is a new topical and peripherally selective androgen receptor antagonist.

 

 

 

 

 

 

RU 58841

RU58841 works by binding to the androgen receptor in the hair follicle. Therefore androgens don’t have the chance to bind and start the chain reaction of androgenetic alopecia and begin the so called miniaturization process. It has been demonstrated to interrupt this hair loss message locally so that normal hair growth could continue.

 

oc000459

OC000459 for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of OC000459 have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery. Recent years have seen the odd study pop up in relation to OC000459 and the treatment of acne and prostate cancer, which are conditions also driven by, however, the most recent study published in relation to OC000459 was back in 2008.

 

Setipiprant

Setipiprant is an orally available, selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T helper [Th]-2 cells) antagonist. CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells. Thus, antagonism of CRTH2 receptors is considered to be a promising therapeutic target for various allergic diseases and asthma.

 

Fevipiprant

Fevipiprant, also known as NVP-QAW039 or QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment. [(3)H]-QAW039 displayed high affinity for the human CRTh2 receptor (1.14 ± 0.44 nM) expressed in Chinese hamster ovary cells, the binding being reversible and competitive with the native agonist prostaglandin D2(PGD2). QAW039 was also a potent inhibitor of PGD2-induced cytokine release in human Th2 cells. Fevipiprant reduces eosinophilic airway inflammation and is well tolerated in patients with persistent moderate-to-severe asthma and raised sputum eosinophil counts despite inhaled corticosteroid treatment. Fevipiprant demonstrates a favorable safety profile.

 

 

 

Packaging & Shipping

 

Our Services

1.A novel R&D center with advanced ventilation equipments and modern experiment equipments.

2.Two Large production factories with high capacity and meet the requirements of GMP.

3.Supplying the products from our manufacturers;

4.Custom synthesis of new products;

5.Help sourcing products and suppliers in China;

6.Assist the export and related affairs.

7.Stable quality,professional production & technology; 

8.The most competitive price;

9.Steady supply, rapid delivery; 

10.Perfect service, honest cooperation.

Company Information

Wuhan HengHeDa Pharm Co., Ltd is a hi-tech enterprise locates in Wuhan Private Science and Technology Park, specializing in custom synthesis, manufacture and import & export of fine chemicals, APIs and pharmaceutical intermediates. HengHeDa Pharm has complete administration management and a good work team, which makes it growing fast in chemicals and pharmaceutical industry.

HengHeDa Pharm has a novel R&D center with advanced ventilation equipments and modern experiment equipments; we offer friendly working environment, have skilled people with rich experience in various kinds of experiments and talent chemists professional in R&D and QC. All of this makes us provide good quality products with high rating.

HengHeDa Pharm follows the principle of “quality first, customer above and credit fundamentality”, wishing to offer the best products to our customers.

 

name card

 

Nancy Chuang (Market Director)

Wuhan Hengheda Pharm Co., Ltd
Skype: nancy_nan4
Tel: 86-27-84888681  Fax: 86-27-84888682
Phone:86-013419582772(what's app & wechat)

 

 

 For research use only! 

 

 

You May Like
Not exactly what you want? 1 request, multiple quotations Get Quotations Now >>
You May Like